{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:50:19Z","timestamp":1785336619312,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["CS-2018-18-ST2-002"],"award-info":[{"award-number":["CS-2018-18-ST2-002"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["RP-2014-05-001"],"award-info":[{"award-number":["RP-2014-05-001"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.coph.2022.102319","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:53:37Z","timestamp":1668858817000},"page":"102319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Novel therapeutic avenues for kisspeptin"],"prefix":"10.1016","volume":"67","author":[{"given":"Jovanna","family":"Tsoutsouki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-2393","authenticated-orcid":false,"given":"Waljit","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102319_bib1","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M104847200","article-title":"The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54","volume":"276","author":"Kotani","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2022.102319_sref2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molmed.2021.05.008","article-title":"Clinical potential of kisspeptin in reproductive health","volume":"27","author":"Abbara","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coph.2022.102319_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1073\/pnas.0409330102","article-title":"Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54","volume":"102","author":"Messager","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102319_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54","volume":"100","author":"De Roux","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102319_bib5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty","volume":"349","author":"Seminara","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2022.102319_bib6","author":"Teles"},{"key":"10.1016\/j.coph.2022.102319_sref7","series-title":"Current perspectives on kisspeptins role in behaviour","first-page":"13","author":"Mills","year":"2022"},{"key":"10.1016\/j.coph.2022.102319_sref8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1210\/clinem\/dgac117","article-title":"Acute effects of kisspeptin administration on bone metabolism in healthy men","volume":"107","author":"Comninos","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_sref9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145889","article-title":"Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model","volume":"132","author":"Guzman","year":"2022","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102319_bib10","series-title":"Kisspeptin in the prediction of pregnancy complications","author":"Tsoutsouki","year":"2022"},{"key":"10.1016\/j.coph.2022.102319_bib11","series-title":"Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men","author":"Scott","year":"2012"},{"key":"10.1016\/j.coph.2022.102319_sref12","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1172\/JCI139681","article-title":"Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders","volume":"130","author":"Abbara","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102319_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/humrep\/dev143","article-title":"Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men","volume":"30","author":"Jayasena","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102319_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2826.2004.01240.x","article-title":"Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis","volume":"16","author":"Thompson","year":"2004","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.coph.2022.102319_bib15","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1210\/jc.2005-1468","article-title":"Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males","volume":"90","author":"Dhillo","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib16","article-title":"Kisspeptin resets the hypothalamic GnRH clock in men","volume":"96","author":"Chan","year":"2011","journal-title":"E908 jcem.endojournals.org J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib17","article-title":"Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men","volume":"8","author":"George","year":"2011","journal-title":"E1228 jcem.endojournals.org J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib18","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2007-1116","article-title":"Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women","volume":"92","author":"Dhillo","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_sref19","first-page":"77","article-title":"Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men","author":"Mills","year":"2021","journal-title":"Endocr Abstr"},{"key":"10.1016\/j.coph.2022.102319_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/clpt.2010.204","article-title":"Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea","volume":"88","author":"Jayasena","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2022.102319_bib21","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/jc.2009-0406","article-title":"Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis","volume":"94","author":"Jayasena","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib22","author":"Jayasena"},{"key":"10.1016\/j.coph.2022.102319_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cen.12179","article-title":"A\u00a0single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women","volume":"79","author":"Jayasena","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2022.102319_bib24","series-title":"Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels","author":"Narayanaswamy","year":"2015"},{"key":"10.1016\/j.coph.2022.102319_bib25","doi-asserted-by":"crossref","first-page":"E1963","DOI":"10.1210\/jc.2011-1408","article-title":"The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans","volume":"96","author":"Jayasena","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib26","article-title":"Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle","volume":"97","author":"Chan","year":"2012","journal-title":"E1458 jcem.endojournals.org J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cen.12103","article-title":"Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism","volume":"79","author":"George","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2022.102319_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000488452","article-title":"Hypothalamic response to kisspeptin-54 and pituitary response to gonadotropin-releasing hormone are preserved in healthy older men","volume":"106","author":"Abbara","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.coph.2022.102319_bib29","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1021\/jm800930w","article-title":"Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase","volume":"51","author":"Tomita","year":"2008","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.coph.2022.102319_bib30","author":"Maclean"},{"key":"10.1016\/j.coph.2022.102319_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2014.03.058","article-title":"Pharmacologic profiles of investigational kisspeptin\/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide","volume":"735","author":"Matsui","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2022.102319_bib32","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2007-1116","article-title":"Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women","volume":"92","author":"Dhillo","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/cen.12103","article-title":"Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism","volume":"79","author":"George","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2022.102319_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2021.04.031","article-title":"Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester","volume":"116","author":"Abbara","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102319_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-021235","article-title":"Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans","volume":"88","author":"Horikoshi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib37","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00555.2005","article-title":"Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment","volume":"291","author":"Dhillo","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib38","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0277-9536(97)00102-0","article-title":"Infertility and psychological distress: a critical review of the literature","volume":"45","author":"Greil","year":"1997","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.coph.2022.102319_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/er.2017-00236","article-title":"Novel concepts for inducing final oocyte maturation in in\u00a0vitro fertilization treatment","volume":"39","author":"Abbara","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2022.102319_bib40","author":"Castillo"},{"key":"10.1016\/j.coph.2022.102319_bib41","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of flt-1 (VEGFR-1) and kdr (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants \u2217","volume":"276","author":"Gille","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2022.102319_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/cen.13569","article-title":"Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment","volume":"88","author":"Abbara","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2022.102319_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00001703-200306000-00007","article-title":"New concepts in the understanding of the ovarian hyperstimulation syndrome","volume":"15","author":"Garcia-Velasco","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.coph.2022.102319_bib44","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1172\/JCI75730","article-title":"Kisspeptin-54 triggers egg maturation in women undergoing in\u00a0vitro fertilization","volume":"124","author":"Jayasena","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102319_bib45","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of kisspeptin-54 to trigger Oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in\u00a0vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/humrep\/dex253","article-title":"A\u00a0second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial","volume":"32","author":"Abbara","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102319_sref47","series-title":"Treatment","first-page":"11","article-title":"Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and kisspeptin during IVF","author":"Abbara","year":"2020"},{"key":"10.1016\/j.coph.2022.102319_bib48","series-title":"Center for reproductive medicine, ren ji hospital","first-page":"355","article-title":"Kisspeptin-10 (Kp-10) inhibits ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) secretion Affiliations : 1","volume":"vol. 154","author":"Zhai","year":"2017"},{"key":"10.1016\/j.coph.2022.102319_bib49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102319_bib50","series-title":"Abbara | Ali, Dhillo WS. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS)","author":"Garg","year":"2022"},{"key":"10.1016\/j.coph.2022.102319_bib51","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/dez205","article-title":"Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome","volume":"34","author":"Romero-Ruiz","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102319_sref52","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/humrep\/deaa104","article-title":"Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome","volume":"35","author":"Skorupskaite","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102319_bib53","series-title":"Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation","author":"Roseweir","year":"2009"},{"key":"10.1016\/j.coph.2022.102319_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179156","article-title":"In\u00a0vitro and in\u00a0vivo effects of kisspeptin antagonists p234, p271, p354, and p356 on GPR54 activation","volume":"12","author":"Albers-Wolthers","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102319_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/jcem-68-2-301","article-title":"Neuroendocrine aberrations in women with functional hypothalamic amenorrhea","volume":"68","author":"Berga","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib56","doi-asserted-by":"crossref","first-page":"E953","DOI":"10.1210\/jc.2013-1569","article-title":"Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of kisspeptin-54","volume":"99","author":"Jayasena","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib57","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1210\/en.2005-0337","article-title":"Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition","volume":"146","author":"Castellano","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102319_bib58","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1172\/JCI63937","article-title":"Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration","volume":"122","author":"Sonigo","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102319_bib59","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/js.2017-00328","article-title":"Hypothalamic-pituitary-ovarian axis reactivation by kisspeptin-10 in hyperprolactinemic women with chronic amenorrhea","volume":"1","author":"Millar","year":"2017","journal-title":"J\u00a0Endocr Soc."},{"key":"10.1016\/j.coph.2022.102319_sref60","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/clinem\/dgac166","article-title":"Kisspeptin overcomes GnRH neuronal suppression secondary to hyperprolactinemia in humans","volume":"107","author":"Hoskova","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102319_bib61","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.3748\/wjg.v20.i36.12956","article-title":"Non-alcoholic fatty liver disease: what the clinician needs to know","volume":"20","author":"Machado","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2022.102319_bib62","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(13)62366-1","article-title":"Sexual function in britain: findings from the third national survey of sexual attitudes and lifestyles (Natsal-3)","volume":"382","author":"Mitchell","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2022.102319_sref63","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133633","article-title":"Kisspeptin enhances brain responses to olfactory and visual cues of attraction in men","volume":"5","author":"Yang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coph.2022.102319_bib64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1172\/JCI89519","article-title":"Kisspeptin modulates sexual and emotional brain processing in humans","volume":"127","author":"Comninos","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102319_bib65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S8756-3282(03)00061-9","article-title":"The components of excess mortality after hip fracture","volume":"32","author":"Kanis","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.coph.2022.102319_bib66","first-page":"3229","article-title":"KISS1 expression in osteosarcoma: high in Chinese clinical cases, but lower in cell lines","volume":"12","author":"Wang","year":"2011","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.coph.2022.102319_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155087","article-title":"The KISS1 receptor as an in\u00a0vivo microenvironment imaging biomarker of multiple myeloma bone disease","volume":"11","author":"Dotterweich","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2022.102319_bib68","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00198-011-1666-2","article-title":"Teriparatide increases the maturation of circulating osteoblast precursors","volume":"23","author":"D'Amelio","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.coph.2022.102319_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10412","article-title":"Zoledronic acid is not equally potent on osteoclasts generated from different individuals","volume":"4","author":"M\u00f8ller","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/j.coph.2022.102319_bib70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1590\/S0004-27302010000200023","article-title":"Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates","volume":"54","author":"de Sousa","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.coph.2022.102319_bib71","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000299767","article-title":"Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes","volume":"91","author":"George","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.coph.2022.102319_bib72","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/en.2005-0195","article-title":"Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats","volume":"146","author":"Kinoshita","year":"2005","journal-title":"Endocrinology"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:59:01Z","timestamp":1761461941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489222001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":72,"alternative-id":["S1471489222001461"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102319","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapeutic avenues for kisspeptin","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102319"}}